Banco Bilbao Vizcaya Argentaria SA Second Tranche of the Share Buyback Program (5894A)

TIDMBVA

RNS Number : 5894A

Banco Bilbao Vizcaya Argentaria SA

03 February 2022

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in compliance with the Spanish Securities Market legislation, hereby proceeds to notify the following:

INSIDE INFORMATION

Further to the notice of Inside Information of 29 October 2021, with registration number 1127 (the "Initial II") ([1]) , and to the notice of Inside Information of 19 November 2021, with registration number 1182 (the "II for First Tranche Execution") ([2]) , the Board of Directors of BBVA has agreed, within the framework of the Program Scheme, to carry out a second buyback program (the "Second Tranche") aimed at reducing BBVA's share capital, for a maximum amount of 2,000 million Euros and a maximum number of shares to be acquired equal to the result of subtracting from 637,770,016 own shares (9.6% of BBVA's share capital at this date) the number of own shares finally acquired in execution of the First Tranche. The implementation of the Second Tranche, which will also be executed externally through a lead-manager, will begin after the end of the implementation of the First Tranche and shall end no later than 15 October 2022 ([3]) .

BBVA will carry out a separate communication prior to the commencement of the execution of the Second Tranche with its specific terms and conditions.

Madrid, 3 February 2022

([1]) The term "Program Scheme" shall have the same meaning as provided in the Initial II.

([2]) The term "First Tranche" shall have the same meaning as provided in the II for First Tranche Execution.

([3]) The preliminary estimated execution term is between 4 and 5 months, although the actual term will be determined in the subsequent communication with the specific terms and conditions of the Second Tranche.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCSSSSWDEESEFE

(END) Dow Jones Newswires

February 03, 2022 02:11 ET (07:11 GMT)